Insights

Regenerative Leadership Target clinics and physician networks involved in regenerative medicine and autologous therapies to expand AdipoCell™ usage and related training programs, leveraging U.S. Stem Cell, Inc.'s large physician network and certification experience.

Clinical Training Offer turnkey physician training and certification partnerships to expand the company's reach, capitalizing on their established track record of training over 700 physicians and growing clinics nationwide.

Clinic Expansion Position as a partner for establishing and managing new stem cell clinics, providing infrastructure, protocols, and governance to accelerate geographic growth and revenue diversification.

Veterinary Synergy Explore cross‑sell opportunities in veterinary stem cell applications to diversify revenue streams and leverage existing regenerative medicine capabilities beyond human treatments.

Public Market Opportunity Leverage the company’s leadership position in regenerative medicine to engage investors and strategic partners, highlighting potential growth through new product lines, clinic networks, and international expansion despite modest current revenue.

Similar companies to U.S. Stem Cell, Inc

U.S. Stem Cell, Inc Tech Stack

U.S. Stem Cell, Inc uses 8 technology products and services including Google AdSense, Amazon Web Services, WordPress, and more. Explore U.S. Stem Cell, Inc's tech stack below.

U.S. Stem Cell, Inc's Email Address Formats

U.S. Stem Cell, Inc uses at least 1 email format:
U.S. Stem Cell, Inc Email FormatsExamplePercentage
FLast@us-stemcell.comJDoe@us-stemcell.com
100%

Frequently Asked Questions

What is U.S. Stem Cell, Inc's phone number?

Minus sign iconPlus sign icon
You can contact U.S. Stem Cell, Inc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is U.S. Stem Cell, Inc's official website and social media links?

Minus sign iconPlus sign icon
U.S. Stem Cell, Inc's official website is us-stemcell.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does U.S. Stem Cell, Inc generate?

Minus sign iconPlus sign icon
As of August 2026, U.S. Stem Cell, Inc's annual revenue is estimated to be $1M - $10M.

What is U.S. Stem Cell, Inc's SIC code and NAICS code?

Minus sign iconPlus sign icon
U.S. Stem Cell, Inc's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does U.S. Stem Cell, Inc have currently?

Minus sign iconPlus sign icon
As of August 2026, U.S. Stem Cell, Inc has approximately 11 employees across 1 continents, including North America. Key team members include President & Ceo: M. T. Explore U.S. Stem Cell, Inc's employee directory with LeadIQ.

What industry does U.S. Stem Cell, Inc belong to?

Minus sign iconPlus sign icon
U.S. Stem Cell, Inc operates in the Biotechnology Research industry.

What technology does U.S. Stem Cell, Inc use?

Minus sign iconPlus sign icon
U.S. Stem Cell, Inc's tech stack includes Google AdSense, Amazon Web Services, WordPress, Microsoft 365, Skrollr, Google Maps, jPlayer and Google Analytics.

What is U.S. Stem Cell, Inc's email format?

Minus sign iconPlus sign icon
U.S. Stem Cell, Inc's email format typically follows the pattern of FLast@us-stemcell.com. Find more U.S. Stem Cell, Inc email formats with LeadIQ.

How much funding has U.S. Stem Cell, Inc raised to date?

Minus sign iconPlus sign icon
As of August 2026, U.S. Stem Cell, Inc has raised $897K in funding. The last funding round occurred on Mar 22, 2021 for $190K.

When was U.S. Stem Cell, Inc founded?

Minus sign iconPlus sign icon
U.S. Stem Cell, Inc was founded in 1999.
U.S. Stem Cell, Inc logo

U.S. Stem Cell, Inc

Biotechnology ResearchFlorida, United States11-50 Employees

U.S. Stem Cell, Inc is a mid-sized biotechnology company based in Fort Lauderdale, Florida, that specializes in regenerative medicine and autologous cell therapies for degenerative conditions. The firm develops physician-delivered stem cell therapies and other regenerative solutions, including its lead product AdipoCell, and also provides physician training, veterinary applications, stem cell banking, and the development and operation of stem cell clinics. Through these activities, the company seeks to enable the body's own healing processes to address a wide range of conditions.

The company reports a robust physician network, having trained and certified more than 700 doctors to deliver its therapies. It emphasizes a physician-based model that spans autologous cell therapies, broader regenerative solutions, and related services such as stem cell banking and clinic management. In 2022, leadership changes occurred with the appointment of Mark Borman as Chairman of the Board as Dr. William P. Murphy Jr transitions to Chairman Emeritus.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1999
Employees
11-50

Section iconFunding & Financials

  • $897K

    U.S. Stem Cell, Inc has raised a total of $897K of funding over 4 rounds. Their latest funding round was raised on Mar 22, 2021 in the amount of $190K as a Post IPO Debt.

  • $1M - $10M

    U.S. Stem Cell, Inc's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.